BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6738769)

  • 1. Rising serum digoxin without further dosage in acute renal failure.
    Gault MH; Gallway B; Fine A; Vasdev S
    Nephron; 1984; 37(3):190-4. PubMed ID: 6738769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of low serum digoxin concentrations in heart failure.
    Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.
    Hoeschen RJ; Cuddy TE
    Am J Cardiol; 1975 Apr; 35(4):469-72. PubMed ID: 1119396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of individual dosage of digoxin with calculated concentration.
    Zhao L; Yang P; Li P; Wang X; Qin W; Zhang X
    Clin Interv Aging; 2014; 9():1205-10. PubMed ID: 25092970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loading dose of digoxin in renal failure.
    Gault MH; Churchill DN; Kalra J
    Br J Clin Pharmacol; 1980 Jun; 9(6):593-7. PubMed ID: 7387815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive performance study of two digoxin assays in subjects with various degrees of renal function.
    Spinler SA; Al-Jazairi AS; Cheng JW; Kapoor S; Kobrin S; Shaw L
    Ther Drug Monit; 2000 Dec; 22(6):729-36. PubMed ID: 11128242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.
    DiDomenico RJ; Bress AP; Na-Thalang K; Tsao YY; Groo VL; Deyo KL; Patel SR; Bishop JR; Bauman JL
    Pharmacotherapy; 2014 Nov; 34(11):1121-31. PubMed ID: 25164709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed digoxin toxicity following discontinuance in acute renal failure.
    Ho AM; Fraser IM; Suria DD
    Can J Anaesth; 1987 Mar; 34(2):178-81. PubMed ID: 3829306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
    Ahmed A; Pitt B; Rahimtoola SH; Waagstein F; White M; Love TE; Braunwald E
    Int J Cardiol; 2008 Jan; 123(2):138-46. PubMed ID: 17382417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum digoxin in children treated with beta methyl digoxin].
    Soler P; García Y; Zilleruelo R; Enríquez G; Eimbcke F; Vicuña D; Jaeger H
    Rev Chil Pediatr; 1991; 62(6):350-4. PubMed ID: 1845639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.
    Ahmed A
    J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):323-9. PubMed ID: 17389731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual dosage of digoxin in patients with heart failure.
    Muzzarelli S; Stricker H; Pfister O; Foglia P; Moschovitis G; Mombelli G; Brunner-La Rocca H
    QJM; 2011 Apr; 104(4):309-17. PubMed ID: 21062754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
    Muk B; Vámos M; Bógyi P; Szabó B; Dékány M; Vágány D; Majoros Z; Borsányi T; Duray GZ; Kiss RG; Nyolczas N
    Clin Cardiol; 2020 Dec; 43(12):1641-1648. PubMed ID: 33140454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioimmune method of determining the concentration of digoxin in the blood during treatment of patients with cardiac insufficiency].
    Dobrotvorskaia TE; Cherniak MS; Grishutina KA
    Kardiologiia; 1976 Dec; 16(12):92-8. PubMed ID: 1011488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part I: Patients with digitalis-induced arrhythmias (author's transl)].
    Doering W; König E; Sturm W
    Z Kardiol; 1977 Mar; 66(3):121-8. PubMed ID: 857452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum glycoside concentrations after single or repeated intravenous doses of beta-methyl-digoxin and digoxin.
    Marinow J; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1977 Mar; 11(3):213-8. PubMed ID: 856604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of verapamil on serum digoxin concentration.
    Klein HO; Lang R; Weiss E; Di Segni E; Libhaber C; Guerrero J; Kaplinsky E
    Circulation; 1982 May; 65(5):998-1003. PubMed ID: 7074765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of determination of digoxin concentration in blood during treatment of cardiac insufficiency].
    Naumov VG; Rossel's AN
    Kardiologiia; 1977 Sep; 17(9):34-9. PubMed ID: 926597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.